Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT: Cytisine and Video Messaging for Perioperative Smoking Cessation
NCT05102123Phase 3Active, not recruiting
- Sponsor
- Population Health Research Institute
- Start
- Jan 2024
- Primary completion
- Jul 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cytisinicline in Tobacco Use Disorder (TUD), sponsored by Population Health Research Institute. Started Jan 2024; status: active, not recruiting.
02
Drugs
cytisinicline
03
Conditions
Tobacco Use Disorder (TUD)
Beyond the preview
Go deeper on NCT05102123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05102123.